College of Optical Sciences, University of Arizona, 1630 E University Blvd., Tucson, AZ 85721 United States; Department of Biomedical Engineering, University of Arizona, Tucson, AZ 85719 United States; Department of Medical Imaging, University of Arizona, Tucson, AZ. 85719 United States.
Department of Biomedical Engineering, University of Arizona, Tucson, AZ 85719 United States.
Ultrasound Med Biol. 2023 May;49(5):1058-1069. doi: 10.1016/j.ultrasmedbio.2022.12.002. Epub 2023 Feb 14.
Phase-change contrast agents (PCCAs) are perfluorocarbon nanodroplets (NDs) that have been widely studied for ultrasound imaging in vitro, pre-clinical studies, and most recently incorporated a variant of PCCAs, namely a microbubble-conjugated microdroplet emulsion, into the first clinical studies. Their properties also make them attractive candidates for a variety of diagnostic and therapeutic applications including drug-delivery, diagnosis and treatment of cancerous and inflammatory diseases, as well as tumor-growth tracking. However, control over the thermal and acoustic stability of PCCAs both in vivo and in vitro has remained a challenge for expanding the potential utility of these agents in novel clinical applications. As such, our objective was to determine the stabilizing effects of layer-by-layer assemblies and its effect on both thermal and acoustic stability.
We utilized layer-by-layer (LBL) assemblies to coat the outer PCCA membrane and characterized layering by measuring zeta potential and particle size. Stability studies were conducted by; 1) incubating the LBL-PCCAs at atmospheric pressure at 37C and 45C followed by; 2) ultrasound-mediated activation at 7.24 MHz and peak-negative pressures ranging from 0.71 - 5.48 MPa to ascertain nanodroplet activation and resultant microbubble persistence. The thermal and acoustic properties of decafluorobutane gas-condensed nanodroplets (DFB-NDs) layered with 6 and 10 layers of charge-alternating biopolymers, (LBLNDs and LBLNDs) respectively, were studied and compared to non-layered DFB-NDs. Half-life determinations were conducted at both 37C and 45C with acoustic droplet vaporization (ADV) measurements occurring at 23C.
Successful application of up to 10 layers of alternating positive and negatively charged biopolymers onto the surface membrane of DFB-NDs was demonstrated. Two major claims were substantiated in this study; namely, (1) biopolymeric layering of DFB-NDs imparts a thermal stability up to an extent; and, (2) both LBLNDs and LBLNDs did not appear to alter particle acoustic vaporization thresholds, suggesting that the thermal stability of the particle may not necessarily be coupled with particle acoustic vaporization thresholds.
Results demonstrate that the layered PCCAs had higher thermal stability, where the half-lifes of the LBLNDs are significantly increased after incubation at 37C and 45C. Furthermore, the acoustic vaporization profiles the DFB-NDs, LBLNDs, and LBLNDs show that there is no statistically significant difference between the acoustic vaporization energy required to initiate acoustic droplet vaporization.
相变对比剂(PCCAs)是全氟碳纳米液滴(NDs),已广泛用于体外超声成像、临床前研究,最近将 PCCA 的一种变体,即微泡-缀合的微滴乳液,纳入了首次临床研究。它们的特性还使它们成为各种诊断和治疗应用的有吸引力的候选物,包括药物输送、癌症和炎症性疾病的诊断和治疗,以及肿瘤生长跟踪。然而,控制 PCCAs 在体内和体外的热和声学稳定性一直是扩大这些试剂在新型临床应用中的潜在用途的挑战。因此,我们的目标是确定层层组装的稳定作用及其对热和声学稳定性的影响。
我们利用层层(LBL)组装来涂覆 PCCA 膜的外层,并通过测量 Zeta 电位和粒径来表征分层。稳定性研究包括:1)在 37°C 和 45°C 下在大气压力下孵育 LBL-PCCAs,然后进行 2)在 7.24 MHz 下进行超声介导的激活,峰值负压范围为 0.71-5.48 MPa,以确定纳米液滴的激活和由此产生的微泡的持久性。研究了用 6 层和 10 层交替带电荷的生物聚合物(LBLNDs 和 LBLNDs)层压的十氟丁烷气体冷凝纳米液滴(DFB-NDs)的热和声学特性,并与非层压 DFB-NDs 进行了比较。在 37°C 和 45°C 下进行半衰期测定,并在 23°C 下进行声滴蒸汽化(ADV)测量。
成功地将多达 10 层带正电荷和负电荷的生物聚合物应用于 DFB-NDs 的表面膜上。本研究证实了两个主要观点;即:(1)DFB-NDs 的生物聚合物层压赋予了热稳定性;并且,(2)LBLNDs 和 LBLNDs 似乎都没有改变颗粒声蒸发的阈值,这表明颗粒的热稳定性不一定与颗粒声蒸发的阈值相关。
结果表明,层压 PCCAs 具有更高的热稳定性,其中 LBLNDs 在 37°C 和 45°C 孵育后半衰期明显延长。此外,DFB-NDs、LBLNDs 和 LBLNDs 的声蒸发曲线表明,启动声滴蒸汽化所需的声蒸发能量之间没有统计学上的显著差异。